BE Opthalmic Suspension [Regulatives / Guidelines]

posted by balakotu – India, 2012-02-07 10:03 (4454 d 14:28 ago) – Posting: # 8063
Views: 5,982

Dear All,

Please help me below query

We are looking to conduct Bioequivalence study on an ophthalmic product “Loteprednol Etabonate” Ophthalmic suspension.

In this study the OGD recommended 90% CI and the acceptance range for Bioequivalence based upon 90% confidence interval of (Rt ±1.645 St) lies with in (0.8, 1.25).

Here,

What is St stands for?

What is the significance of value 1.645 whether it is constant or not.

How to develop Bootstrapping technique by manually or software?

Complete thread:

UA Flag
Activity
 Admin contact
22,986 posts in 4,823 threads, 1,671 registered users;
86 visitors (0 registered, 86 guests [including 5 identified bots]).
Forum time: 01:31 CEST (Europe/Vienna)

Art is “I”; science is “we”.    Claude Bernard

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5